These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3681014)

  • 1. Viral oncolysis in the A2G mouse revisited: monoclonal antibody-mediated tumor rejection.
    Klein PA
    J Interferon Res; 1987 Oct; 7(5):583-9. PubMed ID: 3681014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.
    Lindenmann J; Klein PA
    J Exp Med; 1967 Jul; 126(1):93-108. PubMed ID: 4290961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-cell antigen potentiated by incomplete growth cycle of influenza virus.
    Haller O; Lindenmann J
    J Natl Cancer Inst; 1975 Feb; 54(2):459-64. PubMed ID: 1167598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T; Henderson S; van der Noen HM
    Tumour Biol; 2000; 21(3):145-52. PubMed ID: 10754465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM response and resistance to ascites tumor growth.
    Subiza JL; Coll J; Alvarez R; Valdivieso M; de la Concha EG
    Cancer Immunol Immunother; 1987; 25(2):87-92. PubMed ID: 3664533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus.
    Fiske RA; Klein PA
    Infect Immun; 1975 Mar; 11(3):576-87. PubMed ID: 163800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
    Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
    J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates.
    Gil J; Alvarez R; Viñuela JE; Ruiz de Morales JG; Bustos A; De la Concha EG; Subiza JL
    Cancer Res; 1990 Nov; 50(22):7301-6. PubMed ID: 2224860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and identification of monoclonal antibody against H1N1 influenza virus].
    Liu Y; Zhao X; Guo C; Li Y; Wang G; Liang D; Yu P; Li Y; Hu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):688-694. PubMed ID: 28502308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice.
    Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X
    Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
    Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
    Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids.
    Yamazaki T; Nagashima M; Ninomiya D; Arai Y; Teshima Y; Fujimoto A; Ainai A; Hasegawa H; Chiba J
    Jpn J Infect Dis; 2011; 64(1):40-9. PubMed ID: 21266754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
    Dobaczewska H
    Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
    Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z
    Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP; Mahnel H
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.